21
Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.
Condition(s): Metabolic Clearance Rate Last Updated: November 28, 2005Active, not recruiting
1773 Clinical Trials for: Enzyme Induction, Page 2 of 89
Hide Studies Not Seeking New Volunteers
22
Cholestatic Drug-induced Liver Injury
Condition(s): Hepatitis, Toxic Last Updated: June 8, 2010Recruiting
23
Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism
Condition(s): Alcohol Drinking; Depression; Smoking Cessation; Attention Deficit Disorder Last Updated: April 7, 2008Completed
24
Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions
Condition(s): Adverse Drug Interactions Last Updated: November 12, 2009Active, not recruiting
25
A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723
Condition(s): Mucopolysaccharidosis II Last Updated: May 9, 2013Completed
26
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Condition(s): Recurrent Glioblastoma Multiforme (GBM) Last Updated: April 20, 2011Terminated
27
CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Condition(s): Malignant Pleural Mesothelioma Last Updated: April 12, 2013Recruiting
28
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Condition(s): Kidney Transplantation Last Updated: March 25, 2013Recruiting
29
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
Condition(s): Thrombocytopenia Last Updated: March 11, 2013Terminated
30
Immune Tolerance Study With Aldurazyme® (Laronidase)
Condition(s): Mucopolysaccharidosis I Last Updated: March 18, 2013Recruiting
31
Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition(s): Leukemia Last Updated: May 1, 2013Terminated
32
Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
Condition(s): Non-small Cell Lung Cancer Last Updated: April 12, 2013Withdrawn
33
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Condition(s): Breast Cancer; Cognitive Ability, General; Fatigue; Pain; Psychosocial Deprivation; Radiation Toxicity; Skin Abnormalities Last Updated: April 3, 2013Recruiting
34
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Condition(s): Lung Cancer; Head and Neck Cancer; Hearing Loss; Ototoxicity; Tinnitus; Neuropathy Last Updated: October 14, 2012Not yet recruiting
35
Study of Lipoxysan (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Patients With Breast Cancer
Condition(s): Radiation Induced Dermatitis Last Updated: August 16, 2012Completed
36
Prevention of Irinotecan Induced Diarrhea by Probiotics
Condition(s): Colorectal Cancer Last Updated: September 20, 2012Recruiting
37
Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers
Condition(s): Tuberculosis; Tuberculosis, Pulmonary Last Updated: April 1, 2013Completed
38
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Condition(s): L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Non-T, Non-B Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia Last Updated: May 6, 2013Completed
39
Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment
Condition(s): Cisplatin Ototoxicity Last Updated: March 15, 2012Recruiting
40
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Condition(s): B-cell Childhood Acute Lymphoblastic Leukemia; Peripheral T-cell Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Lymphoblastic Lymphoma; T-cell Childhood Acute Lymphoblastic Leukemia Last Updated: March 26, 2013Recruiting
